Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2022

Institutional positions in Esperion Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
148
+12 vs. Q2 2022
Shares held
63.3M
+8.00M (+14.5%) vs. Q2 2022
Total value
$425.5M
+$73.4M (+20.8%) vs. Q2 2022
New holders
22
59 more added
Sold out
10
41 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 148 institutions
Q1 2021: 156 institutionsQ2 2021: 142 institutionsQ3 2021: 139 institutionsQ4 2021: 133 institutionsQ1 2022: 132 institutionsQ2 2022: 137 institutionsQ3 2022: 148 institutionsQ4 2022: 164 institutionsQ1 2023: 165 institutionsQ2 2023: 124 institutionsQ3 2023: 123 institutionsQ4 2023: 132 institutionsQ1 2024: 152 institutionsQ2 2024: 176 institutionsQ3 2024: 184 institutionsQ4 2024: 190 institutionsQ1 2025: 187 institutionsQ2 2025: 164 institutionsQ3 2025: 189 institutionsQ4 2025: 201 institutionsQ1 2026: 207 institutionsQ2 2026: 191 institutions
Value heldQ3 2022: $425.5M
Q1 2021: $805.3MQ2 2021: $599.4MQ3 2021: $299.4MQ4 2021: $268.0MQ1 2022: $241.2MQ2 2022: $352.1MQ3 2022: $425.5MQ4 2022: $457.6MQ1 2023: $129.1MQ2 2023: $103.6MQ3 2023: $75.9MQ4 2023: $215.3MQ1 2024: $336.2MQ2 2024: $304.2MQ3 2024: $214.3MQ4 2024: $277.9MQ1 2025: $171.5MQ2 2025: $96.6MQ3 2025: $286.1MQ4 2025: $559.6MQ1 2026: $479.3MQ2 2026: $646.8M
Institutions holding ESPR and their total value by quarter
QuarterHoldersValue
Q2 2026191$646.8M
Q1 2026207$479.3M
Q4 2025201$559.6M
Q3 2025189$286.1M
Q2 2025164$96.6M
Q1 2025187$171.5M
Q4 2024190$277.9M
Q3 2024184$214.3M
Q2 2024176$304.2M
Q1 2024152$336.2M
Q4 2023132$215.3M
Q3 2023123$75.9M
Q2 2023124$103.6M
Q1 2023165$129.1M
Q4 2022164$457.6M
Q3 2022148$425.5M
Q2 2022137$352.1M
Q1 2022132$241.2M
Q4 2021133$268.0M
Q3 2021139$299.4M
Q2 2021142$599.4M
Q1 2021156$805.3M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding ESPR in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Walleye Trading LLC14,170$95.0K0.00%+14,170New
ProShare Advisors LLC12,940$88.0K0.00%+948+7.9%Added
Cetera Advisor Networks LLC12,925$87.0K0.00%00.0%Unchanged
Citigroup Inc13,052$87.0K0.00%+8,031+159.9%Added
Mariner, LLC13,048$87.0K0.00%+13,048New
SEI Investments Co12,617$85.0K0.00%+12,617New
Sanders Morris Harris LLC12,200$80.0K0.02%00.0%Unchanged
National Bank of Canada10,918$73.0K0.00%−177−1.6%Reduced
Amalgamated Bank10,530$71.0K0.00%+569+5.7%Added
Independent Advisor Alliance10,206$68.0K0.00%−100−1.0%Reduced
NJ State Employees Deferred Compensation Plan10,125$68.0K0.01%00.0%Unchanged
Alpine Global Management, LLC10,150$68.0K0.02%00.0%Unchanged
Spire Wealth Management10,114$68.0K0.00%00.0%Unchanged
Geneos Wealth Management Inc.9,750$65.0K0.00%−430−4.2%Reduced
FMR LLC8,314$55.0K0.00%−355−4.1%Reduced
Legal & General Group Plc7,645$51.0K0.00%+818+12.0%Added
Advisor Group Holdings, Inc.6,823$47.0K0.00%+3,240+90.4%Added
US Bancorp6,232$42.0K0.00%+584+10.3%Added
Wells Fargo & Company5,341$36.0K0.00%−1,174−18.0%Reduced
Nisa Investment Advisors, LLC3,874$31.0K0.00%+74+1.9%Added
Ameritas Investment Partners, Inc.4,480$30.0K0.00%00.0%Unchanged
Metropolitan Life Insurance Co4,032$27.0K0.00%+1,675+71.1%Added
Signaturefd, LLC3,298$22.0K0.00%+403+13.9%Added
Laurel Wealth Advisors LLC2,500$17.0K0.00%00.0%Unchanged
Aquatic Capital Management LLC2,000$13.0K0.00%−1,600−44.4%Reduced
Money Concepts Capital Corp2,012$13.0K0.00%00.0%Unchanged
Royal Bank of Canada1,588$10.0K0.00%+454+40.0%Added
Quadrant Capital Group LLC1,513$10.0K0.00%+844+126.2%Added
Lindbrook Capital, LLC1,226$8.00K0.00%−22−1.8%Reduced
Dark Forest Capital Management LP550$4.00K0.00%+468+570.7%Added
China Universal Asset Management Co., Ltd.623$4.00K0.00%+623New
Private Trust Co NA400$3.00K0.00%00.0%Unchanged
Parkside Financial Bank & Trust400$3.00K0.00%00.0%Unchanged
Capital Advisors, Ltd. LLC467$3.00K0.00%00.0%Unchanged
Ellevest, Inc.435$3.00K0.00%+43+11.0%Added
First Manhattan Co340$2.00K0.00%−70−17.1%Reduced
South State Corp.314$2.00K0.00%00.0%Unchanged
Trust Co of Vermont300$2.00K0.00%00.0%Unchanged
Benjamin F. Edwards & Company, Inc.325$2.00K0.00%−50−13.3%Reduced
CWM, LLC350$2.00K0.00%00.0%Unchanged
Barrett & Company, Inc.300$1.87K0.00%+300New
Hall Laurie J Trustee135$1.00K0.00%−65−32.5%Reduced
Kistler-Tiffany Companies, LLC100$1.00K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.200$1.00K0.00%00.0%Unchanged
City State Bank200$1.00K0.00%00.0%Unchanged
Wipfli Financial Advisors LLC,184$1.00K0.00%+184New
Parallel Advisors, LLC53$00.00%+18+51.4%Added
Massmutual Trust Co FSB40$00.00%+40New
Voloridge Investment Management, LLC0$00.00%−137,744−100.0%Sold out
Man Group plc0$00.00%–Sold out
Caxton Associates LP0$00.00%−19,768−100.0%Sold out
Caption Management, LLC0$00.00%−12,300−100.0%Sold out
Raymond James & Associates0$00.00%−10,840−100.0%Sold out
Venture Visionary Partners LLC0$00.00%−7,830−100.0%Sold out
Captrust Financial Advisors0$00.00%−2,312−100.0%Sold out
Ahrens Investment Partners LLC0$00.00%−2,000−100.0%Sold out
O'Dell Group, LLC0$00.00%−261−100.0%Sold out
Elequin Capital LP0$00.00%−36−100.0%Sold out
Private Capital Group, LLC––––Not filed